CME Valuation
| CME Stock | USD 303.07 1.43 0.47% |
At this time, the firm appears to be overvalued. CME Group shows a prevailing Real Value of $267.84 per share. The current price of the firm is $303.07. Our model approximates the value of CME Group from examining the firm fundamentals such as Profit Margin of 0.62 %, return on equity of 0.15, and Current Valuation of 107.84 B as well as evaluating its technical indicators and probability of bankruptcy. Key fundamental drivers impacting CME's valuation include:
Price Book 3.7927 | Enterprise Value | Enterprise Value Ebitda 18.4818 | Price Sales 16.7097 | Forward PE 25.7069 |
Overvalued
Today
Please note that CME's price fluctuation is very steady at this time. Calculation of the real value of CME Group is based on 3 months time horizon. Increasing CME's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CME stock is determined by what a typical buyer is willing to pay for full or partial control of CME Group. Since CME is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CME Stock. However, CME's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 303.07 | Real 267.84 | Target 299.29 | Hype 303.08 |
The real value of CME Stock, also known as its intrinsic value, is the underlying worth of CME Group Company, which is reflected in its stock price. It is based on CME's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of CME's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of CME Group helps investors to forecast how CME stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CME more accurately as focusing exclusively on CME's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use CME's intrinsic value based on its ongoing forecasts of CME's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against CME's closest peers. If more than one evaluation category is relevant for CME we suggest using both methods to arrive at a better estimate.
CME Cash |
|
CME Revenue by Product
CME Total Value Analysis
CME Group is currently expected to have company total value of 107.84 B with market capitalization of 108.96 B, debt of 3.42 B, and cash on hands of 2.22 B. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the CME fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
107.84 B | 108.96 B | 3.42 B | 2.22 B |
CME Investor Information
About 92.0% of the company shares are held by institutions such as insurance companies. The book value of CME was currently reported as 79.88. The company recorded earning per share (EPS) of 11.15. CME Group last dividend was issued on the 10th of March 2026. The entity had 5:1 split on the 23rd of July 2012. Based on the measurements of operating efficiency obtained from CME's historical financial statements, CME Group is doing better financially today then in previous quarter. It has a moderate odds of reporting better financial numbers in March.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 4.5 B | 4.2 B |
|
|
CME Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. CME has an asset utilization ratio of 3.29 percent. This indicates that the Company is making $0.0329 for each dollar of assets. An increasing asset utilization means that CME Group is more efficient with each dollar of assets it utilizes for everyday operations.CME Profitability Analysis
Based on the measurements of profitability obtained from CME's financial statements, CME Group may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in March. Profitability indicators assess CME's ability to earn profits and add value for shareholders.Net Income | First Reported 2001-03-31 | Previous Quarter 908 M | Current Value 1.2 B | Quarterly Volatility 385 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.66 | 0.8609 |
|
|
For CME profitability analysis, we use financial ratios and fundamental drivers that measure the ability of CME Group to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well CME utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between CME's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of CME over time as well as its relative position and ranking within its peers.
CME Earnings per Share Projection vs Actual
The next projected EPS of CME is estimated to be 3.0406 with future projections ranging from a low of 2.9321 to a high of 3.2886. CME's most recent 12-month trailing earnings per share (EPS TTM) is at 11.15. Please be aware that the consensus of earnings estimates for CME Group is based on EPS before non-recurring items and includes expenses related to employee stock options.CME Earnings Estimation Breakdown
The calculation of CME's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of CME is estimated to be 3.0406 with the future projection ranging from a low of 2.9321 to a high of 3.2886. Please be aware that this consensus of annual earnings estimates for CME Group is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
2.93 Lowest | Expected EPS | 3.29 Highest |
CME Earnings Projection Consensus
Suppose the current estimates of CME's value are higher than the current market price of the CME stock. In this case, investors may conclude that CME is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and CME's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2026 | Current EPS (TTM) | |
| 15 | 98.1% | 2.77 | 3.0406 | 11.15 |
CME Ownership Allocation
CME holds a total of 359.51 Million outstanding shares. The majority of CME Group outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in CME Group to benefit from reduced commissions. Thereupon, institutional investors are subject to a different set of regulations than regular investors in CME. Please pay attention to any change in the institutional holdings of CME Group as this could imply that something significant has changed or is about to change at the company. Please note that on January 16, 2026, Representative Julie Johnson of US Congress acquired under $15k worth of CME Group's common stock.CME Profitability Analysis
The company reported the last year's revenue of 6.52 B. Total Income to common stockholders was 3.53 B with profit before taxes, overhead, and interest of 6.52 B.CME Past Distributions to stockholders
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates CME's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in CME and how it compares across the competition.
About CME Valuation
The stock valuation mechanism determines CME's current worth on a weekly basis. Our valuation model uses a comparative analysis of CME. We calculate exposure to CME's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CME's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 5.6 B | 5.9 B | |
| Pretax Profit Margin | 0.82 | 0.45 | |
| Operating Profit Margin | 0.65 | 0.43 | |
| Net Profit Margin | 0.62 | 0.33 | |
| Gross Profit Margin | 0.86 | 0.66 |
CME Quarterly Retained Earnings |
|
A single share of CME represents a small ownership stake in the entity. As a stockholder of CME, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
CME Dividends Analysis For Valuation
At present, CME's Dividend Payout Ratio is projected to increase slightly based on the last few years of reporting. The current year's Dividend Paid And Capex Coverage Ratio is expected to grow to 2.08, whereas Dividends Paid is projected to grow to (3.9 B). . As of February 17, 2026, Retained Earnings is expected to decline to about 3.1 B. In addition to that, Retained Earnings Total Equity is expected to decline to about 3.7 B
| Last Reported | Projected for Next Year | ||
| Dividends Paid | -4.1 B | -3.9 B | |
| Dividend Yield | 0.02 | 0.02 | |
| Dividend Payout Ratio | 0.44 | 0.56 | |
| Dividend Paid And Capex Coverage Ratio | 1.15 | 2.08 |
There are various types of dividends CME can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of CME shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from CME Group directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When CME pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of CME by the value of the dividends paid out.
CME Growth Indicators
Investing in growth stocks can be very risky. If the company such as CME does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 360.2 M | |
| Quarterly Earnings Growth Y O Y | 0.35 | |
| Forward Price Earnings | 25.7069 |
CME Current Valuation Indicators
Valuation refers to the process of determining the present value of CME Group and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value CME we look at many different elements of the entity such as CME's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as CME, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use CME's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes CME's worth.Complementary Tools for CME Stock analysis
When running CME's price analysis, check to measure CME's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CME is operating at the current time. Most of CME's value examination focuses on studying past and present price action to predict the probability of CME's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CME's price. Additionally, you may evaluate how the addition of CME to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |